Literature DB >> 8234503

Eye socket reconstruction with free-flap transfer.

H Asato1, K Harii, A Yamada, K Ueda.   

Abstract

Patients afflicted with retinoblastoma or other malignant orbital tumors often undergo eyeball excision and irradiation in infancy, which results in severe deformities of the orbit. It is very difficult to achieve the reconstruction of such severely depressed and contracted eye sockets because both augmentation and formation of an eye socket are required. We usually perform a free-flap transfer with microvascular anastomoses in such situations and have experienced 25 cases since 1980. Various kinds of flaps, such as the groin flap, dorsalis pedis flap, scapular flap, and others, were utilized. The degree of depression and whether sufficient conjunctiva for lining of the eye socket remains are important in the selection and design of the donor flap. To obtain an orbit with a natural appearance, many of the patients required subsequent minor revision operations such as debulking, dermal fat grafts, canthoplasty, fascia suspension, and so on.

Entities:  

Mesh:

Year:  1993        PMID: 8234503     DOI: 10.1097/00006534-199311000-00010

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  3 in total

1.  [Secondary reconstruction of the eye socket with a free radial forearm flap].

Authors:  I Sterker; B Frerich
Journal:  Ophthalmologe       Date:  2007-11       Impact factor: 1.059

2.  Management of radiation-induced severe anophthalmic socket contracture in patients with uveal melanoma.

Authors:  Qasiem J Nasser; Dan S Gombos; Michelle D Williams; B Ashleigh Guadagnolo; William H Morrison; Adam S Garden; Beth M Beadle; Elvia Canseco; Bita Esmaeli
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2012 May-Jun       Impact factor: 1.746

3.  Reconstruction of total lower eyelid defects with the temporoparietal fascial flap.

Authors:  Simon R Bababeygy; Anne R Kao; Niels C Kokot; Eli L Chang
Journal:  Case Rep Ophthalmol Med       Date:  2012-11-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.